Publicacions en què col·labora amb JULIÁN GARCÍA FEIJOO (28)

2024

  1. Chronic Glaucoma Induced in Rats by a Single Injection of Fibronectin-Loaded PLGA Microspheres: IOP-Dependent and IOP-Independent Neurodegeneration

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  2. Influence of sex on chronic steroid-induced glaucoma: 24-Weeks follow-up study in rats

    Experimental Eye Research, Vol. 238

2023

  1. Microesferas biodegradables cargadas con dexametasona para el desarrollo de modelos animales de glaucoma crónico: la influencia de la adición de fibronectina por doble emulsión

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2022

  1. Cytokine profile in tear and aqueous humor of primary open-angle patients as a prognostic factor for trabeculectomy outcome

    European Journal of Ophthalmology, Vol. 32, Núm. 5, pp. 2994-3004

  2. Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres

    Drug Delivery, Vol. 29, Núm. 1, pp. 2357-2374

  3. Nuevas terapias hipotensoras en el tratamiento del glaucoma: New hypotensive therapies in the treatment of glaucoma

    III Congreso Interdisciplinar de Jóvenes Investigadores 23 y 24 de septiembre de 2021

  4. Proinflammatory Cytokine Profile Differences between Primary Open-Angle and Pseudoexfoliative Glaucoma

    Ophthalmic research

2021

  1. Analysis of parainflammation in chronic glaucoma using vitreous-oct imaging

    Biomedicines, Vol. 9, Núm. 12

  2. Chronic glaucoma using biodegradable microspheres to induce intraocular pressure elevation. Six-month follow-up

    Biomedicines, Vol. 9, Núm. 6

  3. Influence of sex on neuroretinal degeneration: Six-month follow-up in rats with chronic glaucoma

    Investigative Ophthalmology and Visual Science, Vol. 62, Núm. 13

  4. Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres

    Drug Delivery, Vol. 28, Núm. 1, pp. 2427-2446

  5. Modelo animal de glaucoma crónico inducido con microesferas biodegradables: influencia de la adición de dexametasona

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 60-62

  6. Novel use of plga microspheres to create an animal model of glaucoma with progressive neuroretinal degeneration

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-20

  7. The effect of a triple combination of bevacizumab, sodium hyaluronate and a collagen matrix implant in a trabeculectomy animal model

    Pharmaceutics, Vol. 13, Núm. 6

2020

  1. CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix

    Human Genetics, Vol. 139, Núm. 10, pp. 1209-1231

2018

  1. Donadores de óxido nítrico como hipotensores en glaucoma

    Archivos de la Sociedad Española de Oftalmologia, Vol. 93, Núm. 6, pp. 290-299

2017

  1. Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma

    Advances in Therapy, Vol. 34, Núm. 2, pp. 378-395

  2. Goniodysgenesis variability and activity of genotypes in primary congenital glaucoma

    PLoS ONE, Vol. 12, Núm. 4

  3. Preliminary study of the differences in optic nerve head hemoglobin measures between patients with and without childhood glaucoma

    Journal of Pediatric Ophthalmology and Strabismus, Vol. 54, Núm. 6, pp. 387-394

  4. Six month delivery of GDNF from PLGA/vitamin E biodegradable microspheres after intravitreal injection in rabbits

    European Journal of Pharmaceutical Sciences, Vol. 103, pp. 19-26